Pacira BioSciences Inc
NASDAQ: PCRX
$17.48
+$0.45 (+2.6%)
Real Time Data Delayed 15 Min.
PCRX Stock Chart and Intraday Price
PCRX Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 5 SYLVAN WAY, SUITE 300, PARSIPPANY, NJ, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 1,340.19M USD |
| Shares Outstanding | 46,437,700 |
PCRX Articles
Friday's top analyst upgrades and downgrades included AT&T, Exxon Mobil, Hasbro, Juniper Networks, Moderna, Palo Alto Networks, Snap, Teva Pharmaceutical, Under Armour and Zscaler.
Published:
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Monday, including Gap, Palo Alto Networks, Schlumberger and Spotify.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Cisco, Lyft, Uber, VMware and more.
Published:
Friday's top analyst upgrades, downgrades and initiations Apple, Centene, Comcast, Electronic Arts, Facebook, Intel, PG&E, Procter & Gamble, SLM, Take-Two Interactive Software and Travelers.
Published:
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Published:
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Published:
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm and Sirius XM.
Published:
Last Updated:
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management in a non-opioid...
Published:
Last Updated:
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial and FDA updates in April.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Allergan, Autodesk, Home Depot, Marvell, Qualcomm, UnitedHealth and Walmart.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile and Wix.com.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Barrick Gold, Buffalo Wild Wings, Caterpillar, Coca-Cola, GrubHub, Nabors Industries and Wynn Resorts.
Published:
Last Updated:
Stocks were indicated to open marginally lower on Monday ahead of the Great American Eclipse, but investors need to keep in mind that the markets are still very close to all-time highs. The one trend...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include Adobe, ClubCorp, Oracle, Silver Wheaton, Weatherford International and Yahoo.
Published:
Last Updated:
In this week's top stock picks from Jefferies, three very prominent biotechnology stocks are featured, including one that is a large cap leader.
Published:
Last Updated: